SOLESENCE, INC. — Director's Dealing 2009

May 6, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES CORPORATION (NANX)
CIK: 0000883107
Period of Report: 2009-05-04

Reporting Person: Nelson David W (VP Sales & Marketing)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-05-04	Common Stock (right to buy)	$1.02	A	30000	Acquired	2019-05-04	Common Stock (30000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock (right to buy)	$6.13	2017-04-09	Common Stock (35000)	35000	Direct
Common Stock (right to buy)	$4.48	2017-11-06	Common Stock (15000)	15000	Direct
Common Stock (right to buy)	$3.14	2018-05-12	Common Stock (20000)	2000	Direct

Footnotes

F1: Subject to certain restrictions, beginning on this date, options vest in five equal anual installments.

F2: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.